Rights and permissions
About this article
Cite this article
Afamelanotide: full insurance reimbursement in Switzerland. Pharmacoecon. Outcomes News 655, 11 (2012). https://doi.org/10.2165/00151234-201206550-00037
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206550-00037